About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
In October 2020, PhRMA added a new chapter on Enhancing Diversity in Clinical Trial Participation its Principles on Conduct in Clinical Trials. With this addition, PhRMA member companies commit to continuing to work with patients, patient advocacy groups, regulatory authorities, healthcare practitioners, academics, and policymakers to define the systematic and impactful approaches that we will take to enhance the diversity of clinical trial participants and help reduce healthcare disparities.
Read the Executive Summary of the Principles here.
PhRMA Principles on Diversity in Conduct of Clinical Trials Executive Summary image
Codes and Guidelines
Clinical Trials
PhRMA Principles on Diversity in Conduct of Clinical Trials Executive Summary
PhRMA Principles on Diversity in Conduct of Clinical Trials Executive Summary image